Researchers employed a specialized brain imaging technique to identify a potential biomarker and therapeutic target for Long COVID. More than four years after the onset of the COVID-19 pandemic, scientists are still working to fully understand the lingering effects of infection with SARS-CoV-2. O
They’ll probably solve every instance of Long Covid but health insurance will deny trying those findings on ME patients.